Pharmapack Podcast: The opportunities and challenges of bringing connected devices to market in the drug delivery sector
Smart, connected devices are revolutionizing drug delivery in the ways they can gather, order and transmit crucial patient data to physicians
Connected smart devices have transformed everyday life in many ways over the last few years. This is particularly evident in the consumer space, where on top of the ‘must-have’ smartphones, computers and wearables, there are now also solutions for recharging, home lighting, managing appliances and energy saving.
However, when it comes to connected drug delivery, the ecosystem is undoubtedly much more complex, not least because it operates in a highly regulated environment. Also, healthcare systems around the world can differ greatly, in terms of clinical practice, pricing and competition and can also be subject to sudden changes brought on by new governmental policy or funding.
Taking all this into account, it is nevertheless an extremely exciting time for product innovators in the drug delivery sector. Digital technology has to all intents and purposes been a real game changer and companies working in this space are finely balancing the opportunity that harnessing the power of this technology can present with the pressing challenge of addressing unmet needs such as patient adherence and compliance.
In this interview with Eric Dessertenne, CEO of BIOCORP and Sebastien Ferrandon, Global Head of Diabetes Integrated Care at Sanofi, we discuss the potential of connected devices, where we are in their story arc and where the future growth opportunities really lie.
Click the link below to listen to the podcast:
Related News
-
.png)
News CPHI Online Webinar Series – Innovative Strategies for B2B Pharma Marketeers
On February 20, 2024, CPHI Online hosted a webinar on Innovative Strategies for B2B Pharma Marketeers. Featuring expert speakers from across the pharmaceutical value chain, this webinar delves into how B2B pharma marketeers can create better content to... -
.png)
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Wegovy® – the weight-loss drug sparking a global race to end obesity
Wegovy®, the weight loss drug from Novo Nordisk has been creating headlines since it’s early testing phases, through it’s approval in June 2021 by the US FDA and January 2022 from the European Medicines Agency, and it continues to do so... -
.png)
News US FDA approves three different oncology drugs in 1 week
In the last week, the US FDA has granted approval/accelerated approval to three different oncology drugs, each from different drugmakers with different indications. -
.png)
News What the Novo Holdings and Catalent deal means for pharma outsourcing
On February 5, 2024, Novo Holdings announced their intention to acquire pharma and biotech CDMO Catalent at US$16.5 billion. Read more about what this means for the pharmaceutical industry as a whole, from drugmakers to their partners in manufacturing.... -
News Key takeaways from Saudi Arabia's National Biotechnology Strategy
In January 2024, Saudi Arabia released its National Biotech Strategy, an ambitious plan to localise biomanufacturing, incentivise R&D and establish the Kingdom as the regional biotech leader by 2030, and an internationally recognised hub by 2040. -
News Novo Holdings buys CDMO Catalent in US$16.5 billion deal
Novo Nordisk’s holding and investment parent company will acquire the publicly owned CDMO at the end of 2024, taking it private and selling three of its drug manufacturing facilities to Novo Nordisk. -
News Special Edition Women in Pharma: International Day of Women and Girls in Science
In this monthly series, we bring insightful content, events, and communities dedicated to sharing best practices for DE&I strategies and showcasing underrepresented voices in the pharmaceutical community.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance